Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies
Antimalarial chemotherapy relies on combination therapies (ACTs) consisting of an artemisinin derivative and a partner drug. Here, the authors study the effects of globally prevalent mutations in a multidrug resistance transporter (PfMDR1) on the parasite’s susceptibility to ACT drugs.
Main Authors: | M. Isabel Veiga, Satish K. Dhingra, Philipp P. Henrich, Judith Straimer, Nina Gnädig, Anne-Catrin Uhlemann, Rowena E. Martin, Adele M. Lehane, David A. Fidock |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2016-05-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms11553 |
Similar Items
-
Balanced impacts of fitness and drug pressure on the evolution of PfMDR1 polymorphisms in Plasmodium falciparum
by: Marvin Duvalsaint, et al.
Published: (2021-06-01) -
Localization of the ATP-binding cassette (ABC) transport proteins PfMRP1, PfMRP2, and PfMDR5 at the <it>Plasmodium falciparum </it>plasma membrane
by: Luty Adrian JF, et al.
Published: (2009-08-01) -
PfMDR1: mechanisms of transport modulation by functional polymorphisms.
by: Pedro Eduardo Ferreira, et al.
Published: (2011-01-01) -
Artemether resistance <it>in vitro</it> is linked to mutations in PfATP6 that also interact with mutations in PfMDR1 in travellers returning with <it>Plasmodium falciparum</it> infections
by: Pillai Dylan R, et al.
Published: (2012-04-01) -
Global Spread of Mutant PfCRT and Its Pleiotropic Impact on Plasmodium falciparum Multidrug Resistance and Fitness
by: Satish K. Dhingra, et al.
Published: (2019-04-01)